These Three Stocks Let You Cash In on the Looming “Short-Squeeze Market”

These Three Stocks Let You Cash In on the Looming “Short-Squeeze Market”

We’re on the doorstep of a “short-squeeze market,” meaning billions of dollars are betting on stocks falling – and billions of dollars are wrong. But with these trades, you can set up to cash in. The president also offered new praise for a Houston-area physician who peddles in conspiracy theories. Dublin, July 29, 2020 (GLOBE NEWSWIRE) — The “Fluoroelastomers Market by Type (FKM, FVMQ, FFKM), Application (O-rings, seals & gaskets, Hoses),… Market Nuggets compiles all of the day’s top expert analysis on the gold market. They offer a short synopsis of bank forecasts, and the outlook of famed economists like Dennis Gartman and Nouriel Roubini. Kitco Nuggets are constantly updated throughout the day. Starting Friday, Bethlehem’s South Greenway is growing to include a new farmer’s market that will feature food and merchandise from Southside business owners.

Until Barry (“Asterisk”) Bonds leapfrogged him 13 years ago, Henry Aaron had been Major League Baseball’s all-time homerun king for more than three decades.

Yet, in one of those cool ironies of life, “Hammerin’ Hank” always said that the “triple was the most exciting play in baseball.”

Let me tell you: I get what “Oh Henry” was saying – the triple is edge-of-your-bleacher-seat exciting. A player drives the ball into the outfield, and it skitters past the fielders and rolls to the wall. Then the player sprints around the bases and slides into third in a cloud of dust – hoping to beat the throw that’s intended to gun him down.

With MLB’s return last week, I caught a couple of Cincinnati Reds games. And I realized that there’s a stock market equivalent to the baseball triple.

You see, the most exciting play in investing is the “short squeeze.”

That’s what happens when an investing pro tries to beat the bullish “shift” in today’s market by betting against a particular stock. And because the loss on that kind of a bearish bet during a bullish rally is potentially unlimited, the pro has to “cover” by purchasing the shares in the open market.

When a whole bunch of bearish pros on a particular stock have to cover all at once – meaning they’re elbowing one another and stampeding through the narrowest of doorways and grabbing shares at every and any price – that stock goes vertical like a ballistic missile.

That’s the “short squeeze.”

And there’s nothing more exciting than having that happen to a stock you already own.

Well, almost nothing.

You see, we’re on the verge of the absolute-most-exciting play in all of investing: It’s something I refer to as an entire “short-squeeze market.”

We’re talking about a nearly vertical ascent to the bull market’s peak.

It’s in the on-deck circle. It’s about to happen.

And here today, in the spirit of that excitement, we’ve created a “triple opportunity” – three short-squeeze market stocks that will let you cash in.

Short sellers bet against the bulls – typically on a company-by-company basis.

They’ve got their reasons. Maybe they think a company has lousy management. Or they see poor execution on the firm’s business strategy. Or they think the stock is overvalued (in layman’s terms, it’s “gone too high”).

And after one of the biggest three-month rallies in history, short sellers have amassed billions of dollars in short positions. If the market keeps marching higher, those positions will start racking up hefty losses for those pros.

To understand why, let’s quickly review the mechanics of a short transaction.

It starts when the short seller borrows the shares of a particular company through a broker – and then immediately sells them in the open market. The proceeds from that sale goes into their account – at least for now.

At this point, this trade’s success is dependent on one thing: The trader has to be able to buy the same stock back at a lower price.

Remember, since the pro “borrowed” the stock that they sold into the market, those shares must be returned to the broker.

The broker doesn’t care what the price of the shares is when they get them back; they just need the shares back.

Think about it as if they had borrowed a car. The car owner doesn’t want cash back; they want the car back. Same thing here.

Let’s make it real – with a real example.

Let’s say we want to short Apple Inc. (NASDAQ: AAPL) when the stock is trading at $400 a share. We borrow 100 shares, sell them at $400 each – and deposit the $40,000 in proceeds into our account.

That sounds awesome, but we don’t own that cash free-and-clear: We still owe the broker those 100 shares of Apple.

Now, say Apple drops to $350 a share – not unreasonable, since that’s where the stock was trading at the end of June.

At that point, we can buy the 100 shares for $35,000, given them back to the broker – and pocket the $5,000 difference (minus any commissions). Since it only took $8,000 to get into this trade, our short sale just netted us a 62.5% profit. (Short trades are done on margin, so typically you need to deposit 20% of the trade total in your account before executing, which in this case would be $8,000, or 20% of $40,000.)

Of course, this can play out another way.

And this other way is painful – even excruciating.

What if Apple shoots up to $450?

Well, we’ve lost $5,000. And with every single dollar the stock climbs, our losses climb, too.

With a straight stock purchase, our losses are limited to what we paid for the shares. But with a short sale – because a stock can keep climbing – our losses are potentially unlimited.

Indeed, the higher the price gets, the greater the pressure to close.

At some point, of course, we’ve got to cut our losses and exit such a loser of a trade.

The terrible irony: To do this, we’ve gotta buy the very stock we were betting against.

It’s the ultimate act of capitulation. And it puts added upward pressure on the shares.

And if the “short interest” on a stock is high – meaning our bearish club has a lot of members, each of them scrambling to buy back shares to stop their bleeding – that upward pressure can have the force of a rocket engine.

That’s why the pros describe this pattern as a “blow-off top.”

A growing number of short sellers are getting caught in these short squeezes worth billions of dollars. Each of these squeezes has the potential to generate short-term bullish opportunities for traders like you and me.

But taken together, they can create a “short-squeeze market.”

And you heard it here first.

For an important bit of context, let’s understand how to ID a short squeeze before it happens (i.e., when it’s in the making).

And I’ve developed a three-step “screen” to do just that.

Short-Squeeze Filter No. 1: Say “Yes SIR.” SIR stands for “short-interest ratio,” a metric calculated by dividing the total short interest for a stock divided by its average daily trading volume. What’s considered a “high” reading? In my 20-plus years of trading and research on short interest, I’ve nailed it down to one easy number – six or higher.

Short-Squeeze Filter No. 2: Be Bullish. Remember, higher prices are Publicly Traded Enemy No. 1 to the short seller. Knowing that, we’re only interested in short-squeeze candidates that are moving higher. Take the list of stocks you created via Screen No. 1, and zero in on those that are in a strong bullish trend. One of the simplest measures of a stock’s trend is the direction of its 50-day moving average. If the stock’s 50-day is trending higher, it’s bullish – and the shorts are feeling some pain.

Short-Squeeze Filter No. 3: Set Your Trigger Price. Determine a “trigger price”-the pain point where the shorts are likely to capitulate – which is where the short-squeeze begins. Good “trigger” candidates are new highs (either 52-week or all-time record), or round numbers such as $20, $50, or multiples of $100. Naturally, these are relative to your starting-point price. But the greater the number of zeros, the greater its potential as a trigger point.

Once you’ve got all three covered, it’s time to get into the stock before the squeeze starts – and before the short sellers start pushing the share price higher as they battle to cover their losing positions.

Let’s look at a recent trade that kicked back a 600% profit.

Alternative energy firm Plug Power Inc. (NASDAQ: PLUG) has long been one of my favorite stocks to watch and trade. Lots of other traders view it the same way – which is good, since that means it’s sensitive to technical trendlines. All that has combined to make it a favorite of short sellers, too – until recently, that is.

  • Short interest on PLUG started building in March as the short sellers started betting against a continuation in PLUG’s rally. My Short Interest Filter (No. 1) tagged the stock as a short squeeze candidate at the end of May, when its short interest ratio went above 6.0. (See the accompanying chart.)
  • A check of Plug Power’s chart shows that that the stock was indeed in a bullish trend (Filter No. 2) as shares were trading above their 50-day moving average – which itself was trending higher. In addition, the stock’s 20-day moving average was turning higher – a confirmation of PLUG’s building bullish momentum.
  • Finally, a trigger price of $7.70 was determinable by the stock’s last rally.
  • Traders could have grabbed PLUG shares for roughly $4.25 ahead of the short squeeze. Options traders could have opened the July $5 Calls for about $0.15 per contract.

    The trigger price was hit on June 4, followed by a rush of buying that drove PLUG shares to $6 each over the following four trading days.

    At that price, the stock position returned a tidy 41%. The option position closed that day at $1.11 per contract, a 640% gain over less than two weeks.

    A 640% gain in less than two weeks is pretty doggone exciting.

    But here’s a bottom line that will rev up any trader: If you invested $1,500 in that options trade, you walked away with $11,100 in less than two weeks.

    This might be even more exciting than a baseball triple.

    Now you know why I like short-squeeze plays so much. And why I love the short-squeeze market.

    And with short interest generally so high right now, there are more than 194 companies that are squeezing the shorts to their tipping point. We’re on the doorstep of a short-squeeze market.

    Indeed, with billions of dollars in short interest bets still open right now, short-squeeze candidates are being created every day.

    Here are the two stocks ready to fly as the shorts get forced into a buying frenzy…

    Focusing on providing digital payment solutions for small- and medium-sized businesses, some might equate PagSeguro Digital Ltd. (NYSE: PAGS) as the PayPal or Square of Brazil. With its shares trading just a few dollars below its trigger price, this Brazilian fintech is starting to make short sellers sweat. Let’s walk through the three “filters” that I use:

  • Short sellers have been busy adding to their bearish bets as the stock has been moving against them. The latest short interest ratio (SIR) on PAGS just hit 8, its highest reading of the year. At the same time, volume on the stock has been low – like the lull before the short-squeeze storm.
  • Being bullish on PAGS is easy. The stock’s 50-day moving average has been in “bull mode” since late May. In addition, shares are trading in a long-term bullish trend. The shorts are feeling a little twitchy as the pain level rises.
  • I love TherapeuticsMD Inc. (NASDAQ: TXMD) as a low-dollar pharmaceutical stock that brings with it a special “kicker.” The company specializes in products for women that range from prenatal vitamins to menopause-related therapies. The recent rally has been as hot as the Florida summer sun, just one of the reasons it’s in the short-squeeze market.

  • The short interest ratio box for TXMD is checked in a big way, as the current SIR sits at 14. This is down from a peak in March, but a look at the chart tells you why. In April, TXMD shares rallied 123% in just a few days. It made another 50% jump in May. This activity will drive the shorts crazy.
  • This stock is putting in a turnaround year as it rallied from below $1 a share back in April to its current $2.09. That’s created a bullish-trend 50-day moving average. What’s more, TXMD is on the threshold of a long-term bullish trend – which is even more energizing.
  • Your trigger price on TXMD is $2.40 – and here’s why. This stock just moved better than 75% in five trading days – though the rally sputtered before the stock could close above its April 30 highs. The short sellers are sweating as they watch the stock trade – knowing full well that another break above $2.40 will cost them dearly.
  • Check Point Software Technologies Ltd. (NASDAQ: CHKP) gave the short sellers a scare last week when the network security company announced better-than-expected earnings results. The stock immediately jumped 5% — nearing all-time highs – but then fell back as traders took profits. But it’s still in the short-squeeze market category – and for good reasons:

  • Short interest has been on the rise for the last two months as the short sellers appeared to get comfortable with the stock’s trading range. Things got a little more interesting over the last month though, as the short interest ratio is now sitting at 11.
  • You heard me when I said “all-time highs”? That’s scary enough, but with Check Point, the trend is definitely the friend, as the 50-day moving average and other supporting technicals are providing the muscle for the stock to move higher. I could see the shares really going for a run.
  • Target Price: $130. This price would put the stock into new all-time-high territory – leapfrogging the record set back in April 2019. The recent pullback is more than likely a “sell the news” reaction to the earnings report. That bearish malaise will evaporate, and the stock will start to run in a rally that steepens as the shorts surrender.
  • Just keep swinging …

    Of course, this is just one of many opportunities out there. You can have expert options trades delivered right to your inbox each week. In fact, I have an exclusive invitation for Money Morning readers.

    Learn how you could capture 52% gains, 78% gains, and even 108% gains in a matter of days, right here.

    Follow Money Morning on Facebook and Twitter.

    About the Author

    Chris Johnson is Quantitative Specialist for Money Map Press. He’s obsessed with building and perfecting mathematical models that allow him to predict, with startling accuracy, the direction of the markets, entire sectors, and individual securities. For the last year, he’s been researching and building a new system that lets him move swiftly in and out of the hottest stocks in the market for life-changing gains – entirely on his own terms. The results of his newly-minted Night Trader system are nothing short of amazing.

    … Read full bio


    Author: Chris Johnson

    Trump, reeling from coronavirus fallout, revives campaign for debunked Covid-19 treatment

    Trump, reeling from coronavirus fallout, revives campaign for debunked Covid-19 treatment

    President Donald Trump and his top White House aides have aggressively renewed their promotion of hydroxychloroquine as an effective treatment for Covid-19, as the administration seeks to shift blame for the resurgence of the coronavirus less than 100 days before the November election.

    Despite robust medical research showing the decades-old antimalarial is not helpful to Covid-19 patients and could even have adverse effects, Trump and his allies have attacked the Food and Drug Administration for warning against its use and touted the drug as a potential way to tame the pandemic.

    White House trade adviser Peter Navarro led the charge Wednesday with his continued defense of hydroxychloroquine in defiance of scientific evidence. But he declined to address the president’s praise for a Houston-area physician who falsely claimed the drug was a coronavirus cure and has promoted other conspiracy theories related to alien DNA and demon sperm.

    In an interview on CNN, Navarro argued “there are two gigantic sides” to the hydroxychloroquine debate — even though the FDA withdrew its emergency-use authorization for the drug last month and at least three studies published earlier this month found it to be an ineffective treatment.

    Navarro, who is assisting with the administration’s coronavirus vaccine development and coordination of the supply chain for personal protective equipment, has clashed repeatedly with public health officials including Dr. Anthony Fauci, the country’s top infectious disease expert, over the efficacy of hydroxychloroquine since the early days of the pandemic.

    “I’m pleading with you and the American people to look at this drug again,” Navarro said. “Because I literally have tens of millions of tablets sitting in the Strategic National Stockpile that — if we were allowed under the doctors’ advice to get this stuff to people at the first sign of their symptoms — I guarantee you it would cut the amount of time of the symptoms, reduce the duration of the symptoms and save lives.”

    Navarro’s advocacy on behalf of hydroxychloroquine has ramped up since a study conducted earlier this month by the Henry Ford Medical Center suggested the drug could help mildly ill patients recover faster from Covid-19.

    But experts have noted that patients who participated in the trial, which did not include a placebo control group, were not randomized and that many were also on steroids known to help with inflammation.

    In an interview Tuesday on ABC, Fauci said the “overwhelming prevailing clinical trials that have looked at the efficacy of hydroxychloroquine have indicated that it is not effective in [treating the] coronavirus disease.”

    And Trump’s former FDA Commissioner Scott Gottlieb told MSNBC on Wednesday that “at this point, we can definitively say hydroxychloroquine doesn’t work.”

    The White House’s new bid to boost hydroxychloroquine comes after Trump had scaled down his hyping of the drug in the spring, and it represents the latest reversal in messaging for a president eager to rectify his diminished standing in virtually all public polling.

    After seemingly projecting a more dire tone when discussing the pandemic at a White House briefing last week, Trump has since returned to undermining his own public health officials and urging governors to reopen their faltering economies.

    “I really do believe a lot of the governors should be opening up states that they’re not opening, and we’ll see what happens with them,” he said Monday during a tour of a vaccine production plant in North Carolina.

    Meanwhile, video has circulated widely among conservatives on social media this week of Stella Immanuel, a pediatrician and religious minister, championing hydroxychloroquine outside the U.S. Supreme Court.

    After Trump retweeted an excerpt of her speech late Monday, Twitter flagged the post and removed it from the president’s feed. Twitter also restricted Donald Trump Jr.’s account Tuesday because he shared a version of the same video.

    Immanuel has claimed that alien DNA is being used in medicine, that scientists are working to create a vaccine to prevent people from being religious, and that certain gynecological problems are caused by people having sex in their dreams with demons and witches, according to a report Tuesday by The Daily Beast.

    Immanuel subsequently tweeted her approval of the story, writing online that “The Daily Beast did a great job summarizing our deliverance ministry and exposing incubus and succubus. Thank you daily beast. If you need deliverance from these spirits. Contact us.”

    Speaking to reporters Wednesday outside the White House, Trump said he was “very impressed” by Immanuel and thought “she made sense” in her viral remarks. “She was making a statement about hydroxychloroquine with other doctors that swear by it. They think it’s great. So she was not alone,” he said.

    “With hydroxy, all I want to do is save lives. I don’t care if it’s hydroxy or anything else. All I want to do is save lives. If we can save lives, that’s great,” Trump added, describing himself as a “believer” in the drug and asserting that “many, many people agree with me.”

    White House press secretary Kayleigh McEnany also said Wednesday that the president “has a positive outlook” for hydroxychloroquine and simply “wants to save lives,” telling CBS News: “That is his goal here, and that’s why he’s promoting this drug as a prophylaxis, but only in consultation with your doctor.”

    McEnany also dismissed Trump’s elevation of Immanuel’s dubious medical advice discouraging the use of face masks. “That was a three-second remark in a more than five-minute video. The overall purpose of that video was for the president to illustrate his views on hydroxychloroquine,” she said.

    Los Angeles-based physician Simone Gold, the leader of the group known as “America’s Frontline Doctors” that orchestrated the news conference Monday where Immanuel spoke, tweeted Tuesday evening that the group had “just met with Vice President Mike Pence to request the administration’s assistance in empowering doctors to prescribe hydroxychloroquine without political obstruction.”

    The president previously applauded Immanuel as “very impressive” at a White House coronavirus briefing Tuesday where he was asked about her fringe health care beliefs.

    “She said that she’s had tremendous success with hundreds of different patients, and I thought her voice was an important voice. But I know nothing about her,” he told reporters.

    Trump, who was prescribed hydroxychloroquine earlier this year, also maintained that “many doctors think it is extremely successful,” saying: “I happen to think it works in the early stages. I think front-line medical people believe that, too.”

    On Wednesday, Navarro said the president discussed hydroxychloroquine “in a very sophisticated way yesterday,” but added that he had “absolutely nothing to say about” Immanuel or Trump’s invocation of her from the White House podium. “I’m not going to be your prop in this circus, OK?” he told CNN.

    But Fauci alluded to Immanuel and the footage of her speech retweeted by the president in an interview Wednesday on MSNBC.

    “When there’s a video out there from a bunch of people spouting something that isn’t true, the only recourse you have is to be very, very clear in presenting the scientific data that essentially contradicts that,” he said.

    Caitlin Oprysko contributed to this report.


    Global Fluoroelastomers Market Outlook 2020-2025, Supply Chain and Ecosystem Analysis with the Impact of COVID-19

    Global Fluoroelastomers Market Outlook 2020-2025, Supply Chain and Ecosystem Analysis with the Impact of COVID-19

    Dublin, July 29, 2020 (GLOBE NEWSWIRE) — The “Fluoroelastomers Market by Type (FKM, FVMQ, FFKM), Application (O-rings, seals & gaskets, Hoses), End-use (Automotive, Aerospace, Chemicals, Oil & Gas, Pharmaceutical & Food, Energy & Power) and Region – Global Forecast to 2025” report has been added to’s offering.

    The global fluoroelastomers market is projected to grow from USD 1.6 billion in 2020 to USD 1.8 billion by 2025, at a compound annual growth rate (CAGR) of 2.5% between 2020 and 2025.

    The global fluoroelastomers industry has witnessed growth primarily because of the strict emission regulations adopted by the automotive industry and the growing demand for more fuel-efficient vehicles.

    The global fluoroelastomers market comprises major manufacturers such as the Chemours Company (US), Solvay SA (Belgium), 3M (US), Asahi Glass Company (Japan), Daikin Industries (Japan) and Gujarat Fluorochemicals Limited (India).

    O-rings application is projected to witness the highest CAGR during the forecast period.

    The o-rings application of the fluoroelastomers market is projected to witness the highest growth during the forecast period. Fluoroelastomer-based O-rings are used in extreme environments due to their capability to resist high temperatures, ozone, oxygen, mineral oils, synthetic hydraulic fluids, and fuels. Due to this, they are used widely in the automotive, aerospace, oil & gas, and chemical industries and are replacing the conventional rubber O-rings in many applications.

    Automotive industry is projected to lead the fluoroelastomers market from 2020 to 2025.

    The automotive industry is expected to lead the fluoroelastomers market. Fluoroelastomers show superior resistance to chemicals and fluids, including fuels and are thus, replacing other conventional elastomers in sealing applications in the automotive industry. They help reduce emissions and increase the fuel efficiency of vehicles.

    North America is projected to account for the maximum revenue share of the fluoroelastomers market during the forecast period.

    North America is projected to lead the global fluoroelastomers market from 2020 to 2025 in terms of value. The large-scale automobile and aircraft production are the key segments that consume the majority of the fluoroelastomers market in the region.

    Research Coverage

    The market study covers the fluoroelastomers market across various segments. It aims at estimating the market size and the growth potential of this market across different segments based on type, material, application, and region. The study also includes an in-depth competitive analysis of key players in the market, along with their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to enhance their position in the fluoroelastomers market.

    Key Topics Covered

    1 Introduction

    2 Research Methodology

    3 Executive Summary

    4 Premium Insights
    4.1 Significant Opportunities in the Fluoroelastomers Market
    4.2 APAC: Fluoroelastomers Market, by Type and Country
    4.3 Fluoroelastomers Market, by Key Countries

    5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
    5.2.1 Drivers Growing Demand for Fuel-Efficient Vehicles Stringent Emission Norms in the Automotive Industry Growth in Major End-Use Industries
    5.2.2 Restraints Rising Environmental Concerns
    5.2.3 Opportunities Industry-Specific Product Development
    5.2.4 Challenges High Price of Fluoroelastomers Lower Capacity Utilization due to the Pandemic
    5.3 Porter’s Five Forces Analysis
    5.3.1 Bargaining Power of Buyers
    5.3.2 Bargaining Power of Suppliers
    5.3.3 Threat from New Entrants
    5.3.4 Threat from Substitutes
    5.3.5 Intensity of Competitive Rivalry
    5.4 Supply Chain & Ecosystem Analysis
    5.4.1 Supply Chain of Fluoroelastomers Market
    5.4.2 Impact of COVID-19 on Supply Chain

    6 Industry Trends
    6.1 Macroeconomic Indicators
    6.1.1 Automotive Industry
    6.1.2 Aerospace Industry
    6.2 YC & YCC Drivers
    6.3 Fluoroelastomers Market Growth Impact Factors
    6.3.1 Automotive Industry
    6.3.2 Aerospace Industry
    6.3.3 Chemical Industry
    6.4 Fluoroelastomers Patent Analysis
    6.4.1 Methodology
    6.4.2 Document Type
    6.4.3 Publication Trends – Last 5 Years
    6.4.4 Insights
    6.4.5 Jurisdiction Analysis
    6.4.6 Top Applicants

    7 Fluoroelastomers Market, by Type
    7.1 Introduction
    7.2 Fluorocarbon Elastomers (FKM)
    7.3 Fluorosilicone Elastomers (FVMQ)
    7.4 Perfluoroelastomers (FFKM)

    8 Fluoroelastomers Market, by Application
    8.1 Introduction
    8.2 O-Rings
    8.3 Seals & Gaskets
    8.4 Hoses
    8.5 Others

    9 Fluoroelastomers Market, by End-use Industry
    9.1 Introduction
    9.2 Automotive
    9.3 Aerospace
    9.4 Chemical
    9.5 Oil & Gas
    9.6 Energy & Power
    9.7 Pharmaceutical & Food
    9.8 Others

    10 Fluoroelastomers Market, by Region
    10.1 Introduction
    10.2 APAC
    10.3 North America
    10.4 Europe
    10.5 South America
    10.6 Middle East & Africa

    11 Competitive Landscape
    11.1 Introduction
    11.2 Competitive Leadership Mapping
    11.2.1 Dynamic Differentiators
    11.2.2 Innovators
    11.2.3 Visionary Leaders
    11.2.4 Emerging Players
    11.3 Market Share Analysis of Key Players
    11.4 Competitive Scenario
    11.4.1 Expansion
    11.4.2 Merger & Acquisition
    11.4.3 Product Launch

    12 Company Profiles
    12.1 The Chemours Company
    12.1.1 Business Overview
    12.1.2 Impact of COVID-19 on the Business Segment
    12.1.3 Production Plant Location
    12.1.4 Products Offered
    12.1.5 Winning Imperatives
    12.1.6 Current Focus and Strategy
    12.1.7 Right to Win
    12.2 Daikin Industries
    12.3 Solvay SA
    12.4 3M
    12.5 Asahi Glass Company (AGC)
    12.6 Dongyue Group
    12.7 Gujarat Fluorochemicals Limited
    12.8 Shin-Etsu Chemicals
    12.9 Halopolymer Ojsc
    12.10 Airboss of America Co.
    12.11 Other Companies
    12.11.1 Eagle Elastomers Inc.
    12.11.2 Greene, Tweed & Co.
    12.11.3 Shanghai Fluoron Chemicals
    12.11.4 Chenguang Fluoro & Silicone Elastomers
    12.11.5 Zhonghao Chenguang Research Institute of Chemical Industry
    12.11.6 Polycomp Bv
    12.11.7 Precision Polymer Engineering
    12.11.8 James Walker & Co.
    12.11.9 Dynafluon
    12.11.10 Marco Rubber & Plastic Products, Inc.

    For more information about this report visit

    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.


    Author: Research and Markets

    Is this gold's market top?

    Is this gold’s market top?

    (Kitco News) Is a price pullback inevitable here as gold settles in above the $1,950 an ounce level? TD Securities says there is some evidence suggesting the gold might be near its market top. “100% of the momentum indicators computed in our ChartVision tool, which aggregates 75 technical signals across momentum and mean-reversion strategies, are pointing long in gold. While not a timing indicator, this has historically coincided with market tops as it has been followed with periods of consolidation,” TD Securities strategists write. Technical positioning also looks overextended, the strategists add. “This coincides with our interpretation of an ‘overshoot’, as excessively positive sentiment, frenzied speculation, and signs that consensus themes are driving trading decisions have all conspired to send gold prices far beyond its observed drivers over the past months. The rally has outpaced the real rate decline and positioning has become bloated, which also suggests that a period of consolidation could be in the cards.” The Federal Reserve interest rate announced will be carefully watched Wednesday afternoon for “any signs of disappointments which could be a catalyst for consolidation.”



    New farmers market to debut Friday at South Bethlehem Greenway

    New farmers market to debut Friday at South Bethlehem Greenway

    Starting Friday, south Bethlehem’s Greenway will host a new farmers market that will feature food and merchandise from South Side business owners.

    The concept was cultivated in the midst of the pandemic, when the Community Action Development Corp. of Bethlehem was looking for ways to promote South Side businesses, said corporation Director Yadira Colon-Lopez.

    “We wanted businesses to be able to get out and sell their products, sell their food and really help sustain themselves and be a little bit more creative during this time,” Colon-Lopez said.

    The city’s rail trail park, the Greenway, is a nearly 2-mile rail trail the follows the former Norfolk Southern line through the city’s South Side neighborhoods. It begins just north of Lehigh University and ends just outside Saucon Park.

    The market will be held at the Polk Street entrance of the Greenway from 2 to 6 p.m. Friday and will continue every Friday through Sept. 25.

    The Community Action Development Corp. has been around for 25 years with the mission of revitalizing the city’s formerly industrialized South Side. This is the first time the group is organizing a farmers market on the Greenway, which will continue next year, Colon-Lopez said. There will be five vendors to start on Friday, with more anticipated in the coming weeks.

    There are also plans to bring in family-oriented entertainment later this summer, such as singalongs and puppet shows.

    It will fill the void left by the Lehigh University farmers market in Farrington Square. That market has been closed this year since the campus shut down because of the coronavirus pandemic. Colon-Lopez said the Greenway Farmers Market isn’t meant to replace the Lehigh Market, however. She hopes the two will be able to co-exist.

    William Seixas, who runs the Couchpota-doh Food Truck with his wife, Marylou Seixas, is excited for the new market.

    “It’s something we’ve been advocating for in the area,” William Seixas said. He lives about three blocks from the Greenway Farmers Market.

    While the Lehigh University market has been popular, Seixas believes the Greenway location will encourage people to walk around and explore other areas of the city. He and his wife have been operating their food truck for five years, making Ecuadorian food from family recipes that have been passed down over the years. Their specialties include oversized empanadas and fried mashed potatoes topped with a fried egg and a red onion salad.

    Jill Matthews, co-owner of Dinky’s Ice Cream on East Third Street, hopes the market provides the push her business needs. She and her husband, Norman Matthews, also own a location in Bangor. They opened the Bethlehem store about six weeks ago, but because of the pandemic, things have been slower than expected.

    “The farmers market is literally going to be in our backyard. I hope this lets people know we are here and what we have,” she said.

    Shannon Van Wert, owner of the Bananarama food truck, said her sales are at a third of what they were last year, since the big festivals she normally attends — such as Mayfair at Cedar Crest College and Blues Brews and Allentown’s Blues Brews and Barbecue Festival — have been canceled.

    Van Wert, who makes dairy-free sundaes out of whipped, frozen bananas, won’t be at the Greenway this Friday, but plans to be there starting next week.

    “I’m definitely excited to be on the South Side of Bethlehem. It’s not easy for us to find places to vend in the city and it’s really nice of them to be thinking of vendors who don’t have an outlet,” she said.

    The new farmers market is made possible by Southside Vision 20/20, a six-year revitalization program of the Community Action Development Corp. of Bethlehem and the city. Last week, city officials approved a roughly four-block area from Webster Street to Pierce Street for the market. Colon-Lopez anticipates eventually having up to five vendors per block.

    Those interested in learning more about the market or how to become a vendor can contact Colon-Lopez at 610-807-9337.

    Morning Call reporter Christina Tatu can be reached at 610-820-6583 or

    The Seed Farm: A nonprofit based in Allentown with a farm in Emmaus. Mission is to support farmland preservation and cultivate the next generation of farmers.

    Couchpota-doh food truck: Serving homemade Ecuadorian food.

    Jenny’s Kuali: Malaysian and vegetarian restaurant.

    Dinky’s Ice Cream Parlor: Homemade ice cream and T-shirts.

    Bread Fermented: Specializing in easy-to-digest ancient grain breads.


    Author: Christina Tatu

    These Three Stocks Let You Cash In on the Looming “Short-Squeeze Market”

    Leave a Comment